Baylor College of Medicine: Novel Approach Identifies Highly Specific Anti-Cancer Compounds
June 07, 2022
June 07, 2022
HOUSTON, Texas, June 7 (TNSjou) -- The Baylor College of Medicine issued the following news:
Researchers at Baylor College of Medicine and Texas Children's Hospital have identified potent, highly specific compounds that interfere with bromodomain (BD)-containing proteins involved in cancer. The compounds, called BET BD1-inhibitors, are a starting point in the development of potentially more effective anti-cancer drugs with less side effects.
The team reports in the . . .
Researchers at Baylor College of Medicine and Texas Children's Hospital have identified potent, highly specific compounds that interfere with bromodomain (BD)-containing proteins involved in cancer. The compounds, called BET BD1-inhibitors, are a starting point in the development of potentially more effective anti-cancer drugs with less side effects.
The team reports in the . . .